Esther Oiknine‐Djian

Hebrew University of Jerusalem

Papers

2

Total Citations

16

H-Index

2

About

Dr. Esther Oiknine-Djian is a molecular virologist whose work has been instrumental in advancing high-throughput diagnostic strategies during the SARS-CoV-2 pandemic. Her primary research focuses on developing extraction-free, early-pooling protocols for massively multiplexed viral detection and variant sequencing. Dr. Oiknine-Djian’s major contribution is the creation of **ApharSeq**, an innovative protocol that eliminates the need for RNA extraction and enables early sample pooling, dramatically increasing testing capacity while reducing costs and turnaround time. This work was further extended in her highly cited 2021 paper on **early sample tagging and pooling**, which demonstrated simultaneous SARS-CoV-2 detection and variant sequencing—a critical capability for tracking viral evolution in real time. With over 16 combined citations for these foundational methods, her protocols have been widely adopted in clinical and research settings, directly addressing global testing shortages. Dr. Oiknine-Djian’s achievements exemplify how clever assay design can bridge the gap between diagnostic speed and genomic surveillance, making her a key figure in pandemic-response innovation.

Research Focus

Key Achievements

2
H-Index
2
Papers
16
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Early sample tagging and pooling enables simultaneous SARS-CoV-2 detection and variant sequencing
11 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Hebrew University of Jerusalem

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago